Chinese newco Brii launches with $260M

Arch Venture Partners and a syndicate of U.S. and Chinese investors launched Brii Biosciences (Shanghai, China) on May 24 with $260 million in committed capital and a series of high-profile partnerships spanning asset acquisition through commercialization and market access.

Arch, 6 Dimensions Capital and Boyu Capital led the round. Yunfeng Capital, Sequoia Capital and Blue Pool Capital also participated...